Skip to main content
. 2020 Aug 1;4:323–325. doi: 10.1016/j.xjtc.2020.07.021

Table 1.

Study and case reports of triple sleeve lobectomies

Solli et al,1 2001 Sekine et al,2 2006 Pochesci et al,3 2008 Sun et al,4 2013
Zhu et al,5 2015 Present report
Case 1 Case 2 Case 3 Case 4
SVC plasty/SVC graft Graft Graft Graft Graft Graft
Pathology ADK SCC SCC Large cell carcinoma ADK ADK SCC SCC Pleomorphic carcinoma
Pathological stage pT4N1M0R0 pT4N2M0R0 NR pT4N2M0R0 pT4N2M0R0 pT4N1M0R0 pT2aN2M0R0 NR pT4N2M0R0
Adjuvant therapy 0 NR NR Cisplatin + gemcitabine Cisplatin + gemcitabine Cisplatin + gemcitabine + radiotherapy Cisplatin + gemcitabine + radiotherapy Cisplatin + gemcitabine + radiotherapy 1 regimen cisplatin + Navelbine
Reported survival Alive at 13 mo More than 3 y Alive at 1 y Alive at 32 mo Died at 21 mo Alive at 38 mo Died at 22 mo Died at 21 mo Died at 54 mo

SVC, Superior vena cava; ADK, adenocarcinoma; SCC, squamous cell carcinoma; NR, not reported.